A validated LC method for the determination of clopidogrel in pharmaceutical preparations
- 3 May 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 28 (3-4) , 431-438
- https://doi.org/10.1016/s0731-7085(01)00620-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapyJournal of the American College of Cardiology, 2000
- Simultaneous determination of benzodiazepines in whole blood or serum by HPLC/DAD with a semi-micro columnJournal of Pharmaceutical and Biomedical Analysis, 2000
- Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide by micro-bore liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1999
- Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Narrow-bore HPLC analysis of isoflavonoid aglycones and theirO- andC-glycosides frompueraria lobataBiomedical Chromatography, 1998
- A first and straightforward approach to detection limits for narrow-bore HPLC and CEBiomedical Chromatography, 1998
- Clopidogrel: a review of its mechanism of actionPlatelets, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Ticlopidine and clopidogrel: Antithrombotic agents that block ADP-mediated platelet activationPerspectives in Drug Discovery and Design, 1994
- Clopidogrel, A Novel Antiplatelet and Antithrombotic AgentCardiovascular Drug Reviews, 1993